연구성과로 돌아가기

2023 연구자 정보 (362 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kim, D. S.
(Kim, DS) ⓘ 		Konyang Univ Hosp, Internal Med, Daejeon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 9.4] Combination treatment of biologics with immunomodulator increases risk of infection after discharge in biologics naive steroid refractory acute severe ulcerative colitis patient: A KASID multicenter study ⓘ SCIE ⓘ 9.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Kim, E. S.
(Kim, ES) ⓘ 		Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ Hosp, Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Internal Med, Sch Med, Daegu, South Korea
Kyungpook Natl Univ, Div Gastroenterol, Dept Internal Med, Sch Med, Daegu, South Korea
Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 9.4] Comparison of Adverse Events of SARS-CoV-2 Vaccination between Patients with Inflammatory Bowel Disease and Healthcare Workers
[JCR상위 9.4] Development of an artificial intelligence model using stool pictures for predicting endoscopic mucosal inflammation in patients with Ulcerative Colitis; KASID multicenter study
[JCR상위 9.4] Combination treatment of biologics with immunomodulator increases risk of infection after discharge in biologics naive steroid refractory acute severe ulcerative colitis patient: A KASID multicenter study
[JCR상위 9.4] Frequency and risk factors of advanced neoplasia in Korean IBD patients with Low Grade Dysplasia in previous surveillance
[JCR상위 14.8] Appropriateness of antibiotic use for patients with asymptomatic bacteriuria or urinary tract infection with positive urine culture: a retrospective observational multi-centre study in Korea
[JCR상위 27.6] Patients from East Asia with acute severe ulcerative colitis have worse endoscopic severity but are more responsive to intravenous steroids than patients from Australasia: Preliminary results of the APAC-ASUC study in collaboration with the ANZIBDC and AOCC ⓘ 		SCIE ⓘ 9.4 GASTROENTEROLOGY & HEPATOLOGY
INFECTIOUS DISEASES;PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH ⓘ 		hbkimmd@snu.ac.kr; ⓘ
Kim, E. Y.
(Kim, EY) ⓘ 		Daegu Catholic Univ, Sch Med, Dept Internal Med, Daegu, South Korea
Daegu Catholic Univ, Internal Med, Sch Med, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 9.4] Comparison of Adverse Events of SARS-CoV-2 Vaccination between Patients with Inflammatory Bowel Disease and Healthcare Workers
[JCR상위 9.4] Development of an artificial intelligence model using stool pictures for predicting endoscopic mucosal inflammation in patients with Ulcerative Colitis; KASID multicenter study ⓘ 		SCIE ⓘ 9.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Kim, Hye Soon
(Kim, HS) ⓘ 		Keimyung Univ, Sch Med, Dept Internal Med, Daegu, South Korea ⓘ CAH-5630-2022
Kim, Hyungduk ⓘ
ⓘ 		[JCR상위 9.4] The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study ⓘ SCIE ⓘ 9.4 ENDOCRINOLOGY & METABOLISM ⓘ kcwon@med.yu.ac.kr; ⓘ
Kim, Jung-Guk
(Kim, JG) ⓘ 		Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 9.4] Novel Asian-Specific Visceral Adiposity Indices Are Associated with Chronic Kidney Disease in Korean Adults ⓘ SCIE ⓘ 9.4 ENDOCRINOLOGY & METABOLISM ⓘ kpark@knu.ac.kr;ykchoi@knu.ac.kr; ⓘ
Kim, K. O.
(Kim, KO) ⓘ 		Yeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea
Yeungnam Univ, Internal Med, Coll Med, Daegu, South Korea
Yeungnam Univ Hosp, Internal Med, Deagu, South Korea
Yeungnam Univ, Div Gastroenterol & Hepatol, Coll Med, Dept Internal Med, Daegu, South Korea
Yeungnam Univ, Coll Med, Gyongsan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 9.4] Comparison of Adverse Events of SARS-CoV-2 Vaccination between Patients with Inflammatory Bowel Disease and Healthcare Workers
[JCR상위 9.4] Development of an artificial intelligence model using stool pictures for predicting endoscopic mucosal inflammation in patients with Ulcerative Colitis; KASID multicenter study
[JCR상위 9.4] Combination treatment of biologics with immunomodulator increases risk of infection after discharge in biologics naive steroid refractory acute severe ulcerative colitis patient: A KASID multicenter study
[JCR상위 9.4] Frequency and risk factors of advanced neoplasia in Korean IBD patients with Low Grade Dysplasia in previous surveillance
[JCR상위 27.6] Patients from East Asia with acute severe ulcerative colitis have worse endoscopic severity but are more responsive to intravenous steroids than patients from Australasia: Preliminary results of the APAC-ASUC study in collaboration with the ANZIBDC and AOCC ⓘ 		SCIE ⓘ 9.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Kim, M. J.
(Kim, MJ) ⓘ 		Sungkyunkwan Univ, Dept Pediat, Sch Med, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 9.4] Proactive dosing is superior to clinically based dosing in terms of endoscopic healing in paediatric patients with Crohn's disease receiving maintenance infliximab: A randomized controlled trial ⓘ SCIE ⓘ 9.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Kim, Nam Hoon
(Kim, NH) ⓘ 		Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea ⓘ U-1356-2019
Kim, Nam ⓘ
ⓘ 		[JCR상위 9.4] The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study ⓘ SCIE ⓘ 9.4 ENDOCRINOLOGY & METABOLISM ⓘ kcwon@med.yu.ac.kr; ⓘ
Kim, S. J.
(Kim, SJ) ⓘ 		제1저자 Chosun Univ, Internal Med, Coll Med, Gwangju, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 9.4] Combination treatment of biologics with immunomodulator increases risk of infection after discharge in biologics naive steroid refractory acute severe ulcerative colitis patient: A KASID multicenter study ⓘ SCIE ⓘ 9.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Kim, Sang Soo
(Kim, SS) ⓘ 		Pusan Natl Univ Hosp, Biomed Res Inst, Dept Internal Med, Busan, South Korea ⓘ A-4448-2018
Kim, Sang Soo ⓘ
ⓘ 		[JCR상위 9.4] The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study ⓘ SCIE ⓘ 9.4 ENDOCRINOLOGY & METABOLISM ⓘ kcwon@med.yu.ac.kr; ⓘ
Kim, Sin Gon
(Kim, SG) ⓘ 		Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea ⓘ KQU-7757-2024
Kim, Sin Gon ⓘ 		0000-0002-7430-3675
Kim, Sin Gon ⓘ 		[JCR상위 9.4] The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study ⓘ SCIE ⓘ 9.4 ENDOCRINOLOGY & METABOLISM ⓘ kcwon@med.yu.ac.kr; ⓘ
Ko, J. S.
(Ko, JS) ⓘ 		Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea ⓘ ABD-2701-2021
Ko, Jae ⓘ
ⓘ 		[JCR상위 9.4] Proactive dosing is superior to clinically based dosing in terms of endoscopic healing in paediatric patients with Crohn's disease receiving maintenance infliximab: A randomized controlled trial ⓘ SCIE ⓘ 9.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Ko, Seung Hyun
(Ko, SH) ⓘ 		Catholic Univ Korea, St Vincents Hosp, Coll Med, Div Endocrinol & Metab,Dept Internal Med, Suwon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 9.4] The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study ⓘ SCIE ⓘ 9.4 ENDOCRINOLOGY & METABOLISM ⓘ kcwon@med.yu.ac.kr; ⓘ
Kolho, K. L.
(Kolho, KL) ⓘ 		Childrens Hosp, Helsinki, Finland
Univ Helsinki, Helsinki, Finland
Tampere Univ, Dept Paediat Gastroenterol, Helsinki, Finland
Tampere Univ Hosp, Tampere, Finland
Univ Tampere, Tampere, Finland
Univ Helsinki, Childrens Hosp, Dept Paediat Gastroenterol, Helsinki, Finland ⓘ
ⓘ
ⓘ 		[JCR상위 9.4] Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN
[JCR상위 9.4] Identification of features associated with poor outcomes in pediatric patients with ulcerative proctitis: A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN ⓘ 		SCIE ⓘ 9.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ ⓘ
Kolho, Kaija-Leena
(Kolho, KL) ⓘ 		Univ Helsinki, Childrens Hosp, Helsinki, Finland
Univ Tampere, Fac Med & Hlth Technol, Tampere, Finland ⓘ
ⓘ
ⓘ 		[JCR상위 9.4] Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN ⓘ SCIE ⓘ 9.4 GASTROENTEROLOGY & HEPATOLOGY ⓘ dror.shouval@gmail.com; ⓘ
페이지 이동: